![](https://i.imgur.com/CLvY2jA.png")
05-09-2021, 08:27 AM
SAO PAULO: Brazil's federal health regulator Anvisa on Saturday (Sep 4) suspended the use of more than 12 million doses of a COVID-19 vaccine developed by China's Sinovac Biotech that were produced in an unauthorised plant, it said in a statement.
Anvisa said it was alerted on Friday by Sao Paulo's Butantan institute, a biomedical centre that has partnered with Sinovac to locally fill and finish the vaccines, that 25 batches, or 12.1 million doses, sent to Brazil had been made in the plant.
Anvisa said it was alerted on Friday by Sao Paulo's Butantan institute, a biomedical centre that has partnered with Sinovac to locally fill and finish the vaccines, that 25 batches, or 12.1 million doses, sent to Brazil had been made in the plant.
